Rybelsus is licensed for adults aged 18 years and over with type 2 diabetes mellitus
An added advantage of GLP-1 medications is their potential to aid in weight loss
The increase in DAG, not only stimulates signal transduction pathways, but also serves as a substrate for the synthesis of 2-arachidonoylglycerol (2-AG)
This week, Nestl showed how seriously its taking the Ozempic trend, with its Health Science unit launching a dedicated website to provide nutritional support for people on weight loss programmes, including GLP-1 medication users
This applies across private plans, Medicaid (which varies by state), and Medicare (which may cover semaglutide for type 2 diabetes but is currently prohibited from covering weight loss medications altogether)
While taking semaglutide, patients are typically advised to follow a reduced-calorie diet and a balanced nutrition plan to support weight loss and improve overall outcomes